View Item 

Show simple item record

Effect of Fenofibrate on Adiponectin and Inflammatory Biomarkers in Metabolic Syndrome Patients
dc.contributor.authorRosenson, Robert S.en_US
dc.date.accessioned2012-10-02T17:20:05Z
dc.date.available2012-10-02T17:20:05Z
dc.date.issued2009-03en_US
dc.identifier.citationRosenson, Robert S. (2009). "Effect of Fenofibrate on Adiponectin and Inflammatory Biomarkers in Metabolic Syndrome Patients." Obesity 17(3). <http://hdl.handle.net/2027.42/93679>en_US
dc.identifier.issn1930-7381en_US
dc.identifier.issn1930-739Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/93679
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Publishing Ltden_US
dc.titleEffect of Fenofibrate on Adiponectin and Inflammatory Biomarkers in Metabolic Syndrome Patientsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelEndocrinologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Cardiovascular Medicine, Department of Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USAen_US
dc.identifier.pmid19023279en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/93679/1/oby.2008.530.pdf
dc.identifier.doi10.1038/oby.2008.530en_US
dc.identifier.sourceObesityen_US
dc.identifier.citedreferenceChoi KC, Ryu OH, Lee KW et al. Effect of PPAR‐α and −γ agonist on the expression of visfatin, adiponectin, and TNF‐α in visceral fat of OLETF rats. Biochem Biophys Res Commun 2005; 336: 747 – 753.en_US
dc.identifier.citedreferenceRosenson RS, Staffileno BA, Tangney CC. Effects of tourniquet technique, order of draw, and sample storage on plasma fibrinogen. Clin Chem 1998; 44: 688 – 690.en_US
dc.identifier.citedreferenceHan SH, Quon MJ, Kim J‐A, Koh KK. Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 2007; 49: 531 – 538.en_US
dc.identifier.citedreferenceTsao T‐S, Tomas E, Murrey HE et al. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity: different oligomers activate different signal transduction pathways. J Biol Chem 2003; 278: 50810 – 50817.en_US
dc.identifier.citedreferenceKoh KK, Quon MJ, Han SH et al. Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia. J Am Coll Cardiol 2005; 45: 1649 – 1653.en_US
dc.identifier.citedreferenceKoh KK, Han SH, Quon MJ, Yeal Ahn J, Shin EK. Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia. Diabetes Care 2005; 28: 1419 – 1424.en_US
dc.identifier.citedreferenceDelerive P, Gervois P, Fruchart JC, Staels B. Induction of IκBα expression as a mechanism contributing to the anti‐inflammatory activities of peroxisome proliferator‐activated receptor‐α activators. J Biol Chem 2000; 275: 36703 – 36707.en_US
dc.identifier.citedreferenceOuchi N, Kihara S, Arita Y et al. Adipocyte‐derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte‐derived macrophages. Circulation 2001; 103: 1057 – 1063.en_US
dc.identifier.citedreferenceWolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti‐inflammatory cytokines IL‐10 and IL‐1RA in human leukocytes. Biochem Biophys Res Commun 2004; 323: 630 – 635.en_US
dc.identifier.citedreferenceKern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin‐6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001; 280: E745 – E751.en_US
dc.identifier.citedreferenceChinetti G, Zawadski C, Fruchart JC, Staels B. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ, and LXR. Biochem Biophys Res Commun 2004; 314: 151 – 158.en_US
dc.identifier.citedreferenceYang WS, Lee WJ, Funahashi T et al. Weight reduction increases plasma levels of an adipose‐derived anti‐inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815 – 3819.en_US
dc.identifier.citedreferenceYang WS, Jeng CY, Wu TJ et al. Synthetic peroxisome proliferator‐activated receptor‐γ agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 2002; 25: 376 – 380.en_US
dc.identifier.citedreferenceForst T, Hohberg C, Fuellert SD et al. Pharmacological PPARγ stimulation in contrast to β cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetes. Horm Metab Res 2005; 37: 521 – 527.en_US
dc.identifier.citedreferenceDesprés J‐P, Golay A, Sjostrom L; Rimonabant in Obesity‐Lipids Study G. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 2005; 353: 2121 – 2134.en_US
dc.identifier.citedreferenceRidker PM, Buring JE, Cook NR, Rifai N. C‐reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8‐year follow‐up of 14 719 initially healthy American women. Circulation 2003; 107: 391 – 397.en_US
dc.identifier.citedreferenceSattar N, Gaw A, Scherbakova O et al. Metabolic syndrome with and without C‐reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414 – 419.en_US
dc.identifier.citedreferencePischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730 – 1737.en_US
dc.identifier.citedreferenceSchulze MB, Shai I, Rimm EB et al. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 2005; 54: 534 – 539.en_US
dc.identifier.citedreferenceCoppack SW. Pro‐inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001; 60: 349 – 356.en_US
dc.identifier.citedreferenceKumar A, Takada Y, Boriek AM, Aggarwal BB. Nuclear factor‐κB: its role in health and disease. J Mol Med 2004; 82: 434 – 448.en_US
dc.identifier.citedreferenceOuchi N, Kihara S, Arita Y et al. Novel modulator for endothelial adhesion molecules: adipocyte‐derived plasma protein adiponectin. Circulation 1999; 100: 2473 – 2476.en_US
dc.identifier.citedreferenceOuchi N, Kihara S, Arita Y et al. Adiponectin, an adipocyte‐derived plasma protein, inhibits endothelial NF‐κB signaling through a cAMP‐dependent pathway. Circulation 2000; 102: 1296 – 1301.en_US
dc.identifier.citedreferenceYokota T, Oritani K, Takahashi I et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000; 96: 1723 – 1732.en_US
dc.identifier.citedreferenceOuchi N, Kihara S, Funahashi T et al. Reciprocal association of C‐Reactive Protein with adiponectin in blood stream and adipose tissue. Circulation 2003; 107: 671 – 674.en_US
dc.identifier.citedreferenceRosenson RS, Wolff DA, Huskin AL, Helenowski IB, Rademaker AW. Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome. Diabetes Care 2007; 30: 1945 – 1951.en_US
dc.identifier.citedreferenceExecutive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III ). JAMA 2001; 285: 2486 – 2497.en_US
dc.identifier.citedreferenceFreedman DS, Otvos JD, Jeyarajah EJ et al. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin Chem 2004; 50: 1189 – 1200.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
oby.2008.530.pdf
Size:
188.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.